Consolidated Statements of Cash Flows - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net income (loss)	[1]	$ 23,065	$ (19,923)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Gain on sale of businesses	[1]	(32,211)	0
Depreciation and amortization	[1]	4,271	5,819
Amortization of debt discounts and deferred financing offering cost	[1]	1,542	1,357
Change in fair value of derivatives liability	[1]	5	0
Change in fair value of Bookings Commitment	[1]	(3,128)	2,494
Stock-based compensation	[1]	653	650
Deferred income taxes, net	[1]	(227)	164
Provision for bad debt expense	[1]	6	10
Loss from related party equity method investment	[1]	1,784	2,210
Changes in operating assets and liabilities:
Accounts receivable, net	[1]	937	(12)
Inventories	[1]	(18)	80
Related party receivables, net	[1]	0	280
Prepaid expenses and other current assets	[1]	15,444	(1,100)
Accounts payable	[1]	(282)	685
Accrued and other current liabilities	[1]	(14,884)	(80)
Deferred revenue	[1]	(1,433)	1,016
Related party payables, net	[1]	1,937	1,727
Change in operating lease right-of-use assets and liabilities	[1]	(95)	(51)
Other operating assets and liabilities	[1]	(109)	(159)
Net cash used in operating activities	[1]	(2,743)	(4,833)
Cash flows from investing activities:
Net proceeds from sale of businesses	[1]	46,401	0
Purchases of property and equipment, including internal-use software	[1]	(935)	(973)
Net cash provided by (used in) investing activities	[1]	45,466	(973)
Cash flows from financing activities:
Repayments of insurance promissory note	[1]	(238)	0
Tax payments related to stock issued, net of stock withheld, for vested equity awards	[1]	0	(58)
Net cash used in financing activities	[1]	(238)	(58)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	[1]	(11)	3
Net increase (decrease) in cash, cash equivalents and restricted cash	[1]	42,474	(5,861)
Cash, cash equivalents and restricted cash, beginning of period	[1],[2]	6,379	19,441
Cash, cash equivalents and restricted cash, end of period	[1],[2]	$ 48,853	$ 13,580

[1] The statements for the three months ended March 31, 2020 and 2019 include the Connected Care Business (see Note 4).

[2] Cash and cash equivalents included restricted cash of $1,136 and $1,375 at December 31, 2019 and March 31, 2020, respectively, included in other assets and $1,136 and $1,136 at December 31, 2018 and March 31, 2019, respectively. Restricted cash consists of funds that are contractually restricted as to usage or withdrawal related to the Company's security deposits in the form of standby letters of credit for leased facilities and funds held in an escrow account related to the sale of the Connected Care Business (see Note 4). No amounts have been drawn upon the letters of credit as of March 31, 2020.